Berkshire Hathaway shares have climbed, but one valuation check argues they may still be priced below a conservative estimate

Berkshire Hathaway’s stock has delivered a sizable gain over the past five years, but a fresh valuation look suggests the shares may still be trading below a conservative estimate of intrinsic value. The analysis, published by Yahoo Finance on Aug. 21, 2026, said Berkshire has generated a 72.5% total return over the prior five-year period, a performance that can complicate attempts to judge whether the stock is “cheap” in valuation terms.

The piece’s central claim is that, despite the gains, current valuation checks indicate the market price still may reflect less value than what the article described as a conservative intrinsic estimate. The writer framed the intrinsic valuation as being derived from an “Excess” approach, which is commonly used in equity analysis to estimate the value of a company based on earnings or cash flow above a required return, though the article’s details are not provided in the available material.

In the context of Berkshire Hathaway, the valuation question matters because the conglomerate’s core business model is not tied to a single operating line. Instead, it spans a range of insurance and insurance-related businesses, a large set of operating subsidiaries, and a substantial equity investment portfolio. That mix is often why analysts debate the appropriate way to value Berkshire, particularly when returns and market sentiment move faster than underlying fundamentals.

The Yahoo Finance note did not assert any new operational change at Berkshire Hathaway itself, nor did it cite a specific near-term catalyst such as a major acquisition, a buyback program update, or a change in guidance. It focused on what the shares appear to be worth relative to an intrinsic-value estimate, which is a market-oriented lens rather than an update on company events.

Even so, investors tend to watch Berkshire closely because the stock’s performance has historically been linked to two broad drivers: the compounding of operating earnings and the market value of its investments. When a valuation check implies the stock remains below a conservative intrinsic-value view, it typically suggests one of two possibilities: either the market price has not kept pace with expected earning power, or the intrinsic model’s assumptions are sufficiently cautious that they still leave room for upside if results match expectations.

A key limitation is that the available information does not include the article’s full methodology, numerical inputs, or the specific intrinsic-value range it referenced, beyond the general description and the mention of the “Excess” framework. Without those details, it is not possible to evaluate how sensitive the estimate is to assumptions, such as future earnings growth, the discount rate used to translate future value into today’s dollars, or how the analysis treated Berkshire’s investment holdings versus operating businesses.

Going forward, the watchpoints for this valuation debate are likely to be incremental rather than dramatic: continued clarity on Berkshire’s underlying earnings trajectory, how investment results evolve as markets change, and whether future intrinsic-value estimates built on conservative assumptions remain above the market price. Until the underlying inputs and assumptions are reviewed in full, the most that can be said from the current material is that the author’s framework still leaves Berkshire looking undervalued relative to a conservative intrinsic estimate.